Riccardo Muzzioli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Riccardo Muzzioli has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- David Piwnica-Worms
Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
10 shared publications - Albert R. Klekers
Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Unit 1473, Houston, TX 77030
9 shared publications - Antrix Jain
Mass Spectrometry Proteomics Core, Baylor College of Medicine, Houston, TX
9 shared publications - Badrajee Piyarathna
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas
9 shared publications - Brittany E. Jewell
Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
9 shared publications - Caroline Fidalgo Ribeiro
Weill Cornell Medical College, New York, NY, USA
9 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 21 (8) , 1883-1890
Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Imaging and Radioligand Therapy
Talazoparib (TZ) is a potent poly(ADP-ribose) polymerase 1/2 (PARP1/2) inhibitor that uniquely traps PARP complexes at sites of single-strand DNA damage thereby offering opportunities for targeted radioligand therapy. Radiolabeled halogenated TZ derivatives were synthesized using boronic ester precursors to enable incorporation of diagnostic and therapeutic radionuclides: 18F for PET imaging, 77Br for Auger electron radiotherapy, and 211At for targeted alpha radiotherapy. Copper-mediated radio-halogenation afforded racemic 18F-TZ, 77Br-TZ, and 211At-TZ in sufficient radiochemical yields (4.3 ± 2.6%, n = 33; 29.0 ± 12.0%, n = 4; 3.6 ± 3.8%, n = 9, respectively), ∼99% radiochemical purity and proven stability under formulation conditions. Molecular dynamics simulations of halo-TZ derivatives predicted an inverse relationship between halogen size and PARP1 binding affinity. Indeed, cell uptake of radio-halogenated TZ analogues indicated selective uptake in a panel of cell types that correlated with PARP1 levels but was inversely related to the atomic radii of the halogen series. Despite modest specific activity and specific uptake, 77Br-TZ showed significant cytotoxicity. Further investigation of 18F-TZ with 77Br-TZ as a radiotheranostic pair will be facilitated by the synthetic schemes herein.
- 27 July 2026
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 21 (8) , 1883-1890
Open AccessSynthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Imaging and Radioligand Therapy
Talazoparib (TZ) is a potent poly(ADP-ribose) polymerase 1/2 (PARP1/2) inhibitor that uniquely traps PARP complexes at sites of single-strand DNA damage thereby offering opportunities for targeted radioligand therapy. Radiolabeled halogenated TZ derivatives were synthesized using boronic ester precursors to enable incorporation of diagnostic and therapeutic radionuclides: 18F for PET imaging, 77Br for Auger electron radiotherapy, and 211At for targeted alpha radiotherapy. Copper-mediated radio-halogenation afforded racemic 18F-TZ, 77Br-TZ, and 211At-TZ in sufficient radiochemical yields (4.3 ± 2.6%, n = 33; 29.0 ± 12.0%, n = 4; 3.6 ± 3.8%, n = 9, respectively), ∼99% radiochemical purity and proven stability under formulation conditions. Molecular dynamics simulations of halo-TZ derivatives predicted an inverse relationship between halogen size and PARP1 binding affinity. Indeed, cell uptake of radio-halogenated TZ analogues indicated selective uptake in a panel of cell types that correlated with PARP1 levels but was inversely related to the atomic radii of the halogen series. Despite modest specific activity and specific uptake, 77Br-TZ showed significant cytotoxicity. Further investigation of 18F-TZ with 77Br-TZ as a radiotheranostic pair will be facilitated by the synthetic schemes herein.
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary File 1 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
Supplementary Dataset of Phosphoproteomics Analyses of Patient Samples
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary File 1 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
Supplementary Dataset of Phosphoproteomics Analyses of Patient Samples
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary File 1 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
Supplementary Dataset of Phosphoproteomics Analyses of Patient Samples
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary File 1 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
Supplementary Dataset of Phosphoproteomics Analyses of Patient Samples
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary File 2 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
IP/MS summary table describing the ATGL interactome in C4-2 cells.
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary File 2 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
IP/MS summary table describing the ATGL interactome in C4-2 cells.
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Tables 1-8 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
Supplementary Tables 1-8 to accompany the main text and, in particular, the materials and methods.
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables 1-8 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
Supplementary Tables 1-8 to accompany the main text and, in particular, the materials and methods.
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary File 2 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
IP/MS summary table describing the ATGL interactome in C4-2 cells.
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary File 2 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
IP/MS summary table describing the ATGL interactome in C4-2 cells.
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S28 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
28 supplementary figures supporting the main text and main figures.
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S28 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
28 supplementary figures supporting the main text and main figures.
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S28 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
28 supplementary figures supporting the main text and main figures.
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S28 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
28 supplementary figures supporting the main text and main figures.
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Tables 1-8 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
Supplementary Tables 1-8 to accompany the main text and, in particular, the materials and methods.
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables 1-8 from Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity
Supplementary Tables 1-8 to accompany the main text and, in particular, the materials and methods.
- Open Access
- 18 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 1174
The Interaction and Effect of a Small MitoBlock Library as Inhibitor of ALR Protein–Protein Interaction Pathway
MIA40 and ALR of the MIA pathway mediate the import of protein precursors that form disulfides into the mitochondrial intermembrane space. This import pathway is suggested to be a linear pathway in which MIA40 first binds to the precursor via a disulfide linkage and oxidizes it. Subsequently, ALR re-oxidizes MIA40 and then ALR transfers electrons to terminal electron acceptors. However, the precise mechanism by which ALR and MIA40 coordinate translocation is unknown. With a collection of small molecule modulators (MB-5 to MB-9 and MB-13) that inhibit ALR activity, we characterized the import mechanism in mitochondria. NMR studies show that most of the compounds bind to a similar region in ALR. Mechanistic studies with small molecules demonstrate that treatment with compound MB-6 locks the precursor in a state bound to MIA40, blocking re-oxidation of MIA40 by ALR. Thus, small molecules that target a similar region in ALR alter the dynamics of the MIA import pathway differently, resulting in a set of probes that are useful for studying the catalysis of the redox-regulated import pathway in model systems.
- 18 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 1174
Open AccessThe Interaction and Effect of a Small MitoBlock Library as Inhibitor of ALR Protein–Protein Interaction Pathway
MIA40 and ALR of the MIA pathway mediate the import of protein precursors that form disulfides into the mitochondrial intermembrane space. This import pathway is suggested to be a linear pathway in which MIA40 first binds to the precursor via a disulfide linkage and oxidizes it. Subsequently, ALR re-oxidizes MIA40 and then ALR transfers electrons to terminal electron acceptors. However, the precise mechanism by which ALR and MIA40 coordinate translocation is unknown. With a collection of small molecule modulators (MB-5 to MB-9 and MB-13) that inhibit ALR activity, we characterized the import mechanism in mitochondria. NMR studies show that most of the compounds bind to a similar region in ALR. Mechanistic studies with small molecules demonstrate that treatment with compound MB-6 locks the precursor in a state bound to MIA40, blocking re-oxidation of MIA40 by ALR. Thus, small molecules that target a similar region in ALR alter the dynamics of the MIA import pathway differently, resulting in a set of probes that are useful for studying the catalysis of the redox-regulated import pathway in model systems.